These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11176816)

  • 1. Nonresponse to interferon in chronic hepatitis C: re-treatment redux.
    Koff R
    JAMA; 2001 Jan; 285(2):212-4. PubMed ID: 11176816
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
    Lo GH
    Hepatology; 2009 Sep; 50(3):988; author reply 988-9. PubMed ID: 19714721
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders.
    Glaser D
    Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of conventional interferon and ribavirin combination therapy in chronic Hepatitis C patients in Pakistan.
    Bukhsh A; Goh BH; Lee LH; Khan TM
    J Infect Public Health; 2017; 10(5):692-693. PubMed ID: 28209323
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov; 144(45):56-7. PubMed ID: 12534066
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of peginterferon α-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.
    Husa P; Oltman M; Ivanovski L; Rehák V; Messinger D; Tietz A; Urbanek P
    Eur J Gastroenterol Hepatol; 2011 May; 23(5):375-81. PubMed ID: 21502923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions.
    Douglas SD
    Brain Behav Immun; 2005 Jan; 19(1):20-2. PubMed ID: 15581734
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    Alavian SM; Tabatabaei SV
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficiency of second pegylated interferon and ribavirin combination treatment for the relapsed hepatitis C virus infection in low-income countries.
    Ceylan B; Arslan F; Yardimci C; Fincanci M; Özgüneş N
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):493-4. PubMed ID: 24598385
    [No Abstract]   [Full Text] [Related]  

  • 10. Retreatment of interferon relapse patients with chronic hepatitis C.
    Buti M; Esteban R
    J Hepatol; 1999; 31 Suppl 1():174-7. PubMed ID: 10622582
    [No Abstract]   [Full Text] [Related]  

  • 11. Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients.
    van Vlerken LG; Huisman EJ; van Soest H; Boland GJ; Drenth JP; Siersema PD; Burger DM; van Erpecum KJ
    J Viral Hepat; 2012 Jan; 19(1):39-46. PubMed ID: 21114586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic hepatitis C in patients without previous treatment].
    Dehesa Violante M
    Rev Gastroenterol Mex; 2002 Oct; 67 Suppl 2():S42-4. PubMed ID: 12712852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis C in patients not responding to interferon].
    Moreno Monteagudo JA; García Buey L; Moreno Otero R
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():51-6. PubMed ID: 11968345
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials.
    Cummings KJ; Lee SM; West ES; Cid-Ruzafa J; Fein SG; Aoki Y; Sulkowski MS; Goodman SN
    JAMA; 2001 Jan; 285(2):193-9. PubMed ID: 11176813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule].
    Horváth G; Tolvaj G; Halász T; Stotz G
    Orv Hetil; 2007 Aug; 148(33):1545-50. PubMed ID: 17686672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment].
    Zoulim F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B225-30. PubMed ID: 12180293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic hepatitis C. Combined treatment in naive patients].
    Forns Bernhardt X
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():43-6. PubMed ID: 11968343
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evolution of Sjögren syndrome associated with hepatitis C virus when chronic hepatitis C is treated by interferon or the association of interferon and ribavirin].
    Doffoël-Hantz V; Loustaud-Ratti V; Ramos-Casals M; Alain S; Bezanahary H; Liozon E; Fauchais AL; Vidal E
    Rev Med Interne; 2005 Feb; 26(2):88-94. PubMed ID: 15710254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up to date treatment of hepatitis C in adults.
    Schalm SW; Brouwer JT
    Acta Gastroenterol Belg; 1998; 61(4):397-9. PubMed ID: 9923088
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment strategies for viral hepatitis].
    Matsushima T
    Hokkaido Igaku Zasshi; 2002 Mar; 77(2):133-5. PubMed ID: 11968844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.